Registered Health shortage of potential medicines for COVID-19



Mexico.- The undersecretary of Prevention and Health Promotion, Hugo López-Gatell, reported that there is a shortage in the country of two drugs currently in studies that could combat the COVID-19.

At a press conference, explained that it is the chloroquine and hydroxychloroquine, which are drugs used for the treatment of malaria and rheumatic diseases such as lupus and rheumatoid arthritis.

The problem with the shortage, he said, is that there are people who actually need these drugs to treat their diseases and the shopping of panic limited to these patients access to their treatments.

“Unfortunately, when circulated news that these two drugs might be useful for the treatment of coronavirus is precipitated a kind of shopping panic, completely unjustified.

“(Until now), there is no scientific demonstration that these are useful medicines for the new coronavirus COVID-19”, he said.

Noted that is currently being considered by the Federal Commission for Protection against Sanitary Risks (Cofepris) if you should put some kind of regulation, and limit consumption of these drugs.